Global colorless peritoneal dialysis solution market is expanding as healthcare systems continue to develop home-based kidney-care pathways and improve access to peritoneal dialysis. Valued at USD 1.20 billion in 2025, the market is estimated at USD 1.26 billion in 2026 and is projected to reach USD 1.90 billion by 2034, registering a CAGR of 5.3% from 2026 to 2034.
Colorless peritoneal dialysis solutions are sterile dialysis fluids intended for intraperitoneal use in peritoneal dialysis. Demand is closely connected to patients receiving continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD), as each patient requires recurring supplies of dialysis solution.
Access the complete report https://www.24lifesciences.com/colorless-peritoneal-dialysis-solution-market-15361
Emerging Healthcare Trends Shaping Market Evolution
The expansion of home dialysis is an important trend influencing demand for peritoneal dialysis solutions. According to the report, U.S. incident home-dialysis use increased from 8.5% of ESRD patients in 2012 to 14.5% in 2022, with much of the increase associated with peritoneal dialysis.
Canada also demonstrates established use of home peritoneal dialysis, with APD and CAPD together representing 18.2% of prevalent dialysis patients in 2024.
The market is also evolving through improvements in solution formulations and digital home-care technologies. Traditional solutions continue to provide a broad demand base, while bicarbonate-based and low-glucose-degradation-product formulations create opportunities for differentiated products.
Quality and supply continuity are equally important. Sterile bag integrity, manufacturing controls, logistics, and reliable delivery are critical because patients depend on recurring solution supplies.
Key Market Drivers Supporting Long-Term Expansion
Increasing prevalence of kidney failure
Expansion of home peritoneal dialysis
Recurring consumption of dialysis solution bags
Growing investment in kidney-care infrastructure
Development of low-GDP and biocompatible formulations
Expansion of digital home-dialysis monitoring
Increasing focus on treatment accessibility and home-based care
The recurring nature of solution consumption makes PD fluid demand closely connected to the installed patient base and the proportion of dialysis patients using home therapies.
Download segment insights https://www.24lifesciences.com/download-sample/15361/colorless-peritoneal-dialysis-solution-market
Competitive Landscape: Companies Supporting Kidney-Care Solutions
The market includes major kidney-care companies, medical-device manufacturers, pharmaceutical companies, and regional suppliers.
Vantive – focuses on kidney and vital-organ therapies, including home-dialysis technologies.
Fresenius Medical Care – maintains a broad kidney-care portfolio and dialysis infrastructure.
B. Braun Melsungen – provides dialysis products and renal-care technologies.
Terumo Corporation – participates in medical-device and healthcare technologies.
Nipro Corporation – maintains a significant presence in dialysis-related products.
Asahi Kasei Medical – provides renal-care and medical technologies.
Other companies profiled include Huaren Pharmaceutical, Tianjin Tianan Pharmaceutical, China Resources Double-Crane Pharmaceutical, Chengdu Qingshan Likang Pharmaceutical, WEGO Group, and other regional suppliers.
Segment Insights & Regional Overview
By Type, the market is segmented into single-bag and double-bag solutions. Single-bag solutions represent the leading type within the report structure, while double-bag configurations provide alternative packaging and formulation capabilities.
By Application, the market covers renal failure, heart failure, edema, and other applications. Renal failure represents the primary demand base because peritoneal dialysis is fundamentally used as a kidney-replacement therapy.
By End User, the market includes hospitals, dialysis centers, and home-care settings. Home care represents an important growth channel because CAPD and APD enable recurring treatment outside conventional dialysis-center environments.
By Distribution Channel, the report covers direct sales, medical distributors, and online pharmacies.
By Technology, products are classified as traditional solutions, bicarbonate-based solutions, and low-GDP solutions. These categories reflect differences in formulation and clinical characteristics rather than the physical appearance of the solution.
Regionally, North America leads the market and accounted for approximately 42% of report-model revenue in 2025. Asia-Pacific provides significant expansion potential as renal-care infrastructure and home-therapy capacity develop. Europe remains an established dialysis market, while Latin America and the Middle East & Africa provide additional opportunities as healthcare access and home-treatment infrastructure improve.
Explore market forecasts https://www.24lifesciences.com/colorless-peritoneal-dialysis-solution-market-15361
Technological Advancements & Strategic Outlook
Can Home-Based Kidney Care Reshape the Peritoneal Dialysis Solution Market?
Technology development is increasingly extending beyond solution formulation toward digital monitoring, connected home-care systems, supply-chain management, and patient-support services.
Vantive has announced investments exceeding USD 1 billion over five years in kidney-care R&D and production capacity, while digital platforms such as Vantive CONNECT and Fresenius Medical Care’s kinexus demonstrate the growing role of connected home-therapy management.
Key Benefits of the 24LifeSciences Report
Market sizing and forecasts through 2034
Analysis by bag type, application, end user, distribution channel, and technology
Regional market assessment
Competitive analysis of leading kidney-care companies
Evaluation of home-dialysis adoption
Review of formulation and digital-care trends
Assessment of supply, sterility, and manufacturing considerations
Review competitive analysis https://www.24lifesciences.com/colorless-peritoneal-dialysis-solution-market-15361
Future Perspective
The colorless peritoneal dialysis solution market is expected to maintain steady expansion as healthcare providers increase access to home-based renal therapies and manufacturers develop more differentiated dialysis solutions.
Future growth will depend on the expansion of home-dialysis infrastructure, reimbursement, patient training, reliable sterile-fluid manufacturing, supply continuity, and connected-care technologies. Together, these factors will shape the evolution of this essential renal-care consumables market.
About 24LifeSciences
Founded in 2017, 24LifeScience provides research and analytics across the global life sciences and healthcare industries, delivering market intelligence designed to support strategic decision-making.
Asia: +91 9425150513
Website: http://www.24lifesciences.com
